Secondary prevention of stroke is important: but all hypertensive drugs are not created equal?

Strandberg, Timo E

Secondary prevention of stroke is important: but all hypertensive drugs are not created equal? [electronic resource] - Stroke Jun 2005 - 1225-6 p. digital

Publication Type: Comment; Editorial

1524-4628

10.1161/01.STR.0000166044.06026.46 doi


Angiotensin II Type 1 Receptor Blockers--therapeutic use
Animals
Antihypertensive Agents--therapeutic use
Brain Ischemia--drug therapy
Clinical Trials as Topic
Humans
Hypertension--drug therapy
Ischemic Attack, Transient--pathology
Myocardial Infarction--etiology
Research Design
Risk
Stroke--pathology